Best buy interventions to address the burden of steatotic liver disease,The Lancet Gastroenterology & Hepatology

当前位置： X-MOL 学术 › Gastroenterol. Hepatol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Best buy interventions to address the burden of steatotic liver disease
The Lancet Gastroenterology & Hepatology ( IF 30.9 ) Pub Date : 2024-09-03 , DOI: 10.1016/s2468-1253(24)00220-6
Jeffrey V Lazarus ₁ , Henry E Mark ₂ , Naim Alkhouri ₃ , Luis Antonio Díaz ₄ , Ajay Duseja ₅ , C Wendy Spearman ₆ , Maja Thiele ₇ , Vincent Wai-Sun Wong ₈ , Zobair M Younossi ₉

Affiliation

City University of New York Graduate School of Public Health and Health Policy, New York, NY, USA; Barcelona Institute for Global Health, Hospital Clínic, University of Barcelona, Barcelona, Spain.
City University of New York Graduate School of Public Health and Health Policy, New York, NY, USA.
Arizona Liver Health, Chandler, AZ, USA.
Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Center for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, and Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Medical Data Analytics Center, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China.
Global NASH Council, Washington DC, USA; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, VA, USA.

中文翻译：

解决脂肪性肝病负担的百思买干预措施

更新日期：2024-09-03

点击分享查看原文

点击收藏

阅读更多本刊新发论文